These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1853922)

  • 1. Daily administration of the progesterone antagonist RU 486 prevents implantation in the cycling guinea pig.
    Batista MC; Bristow TL; Mathews J; Stokes WS; Loriaux DL; Nieman LK
    Am J Obstet Gynecol; 1991 Jul; 165(1):82-6. PubMed ID: 1853922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-implantation activity of antiestrogens and mifepristone.
    Dao B; Vanage G; Marshall A; Bardin CW; Koide SS
    Contraception; 1996 Oct; 54(4):253-8. PubMed ID: 8922879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigestogens.
    Baird DT
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs.
    Elger W; Fähnrich M; Beier S; Qing SS; Chwalisz K
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1065-74. PubMed ID: 3479025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
    Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
    Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraceptive use of antiprogestin.
    Bygdeman M; Danielsson KG; Marions L; Swahn ML
    Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):103-7. PubMed ID: 10427485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal requirement for blastocyst implantation and a new approach for anti-implantation strategy.
    Ghosh D; Nayak NR; Kumar PG; Dhara S; Sengupta J
    Indian J Physiol Pharmacol; 1997 Apr; 41(2):101-8. PubMed ID: 9142552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin F2 alpha concentrations.
    Gemzell-Danielsson K; Hamberg M
    Hum Reprod; 1994 Sep; 9(9):1626-30. PubMed ID: 7836511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postcoital use of anordrin and RU 486 for prevention of implantation in the rat.
    Chang CC; Wang WC; Bardin CW
    Contraception; 1993 Apr; 47(4):413-9. PubMed ID: 8508670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postcoital administration of RU486 induces a hormonally under-stimulated rat endometrium.
    Theron KE; Penny CB; Hosie MJ
    Reprod Biol; 2014 Sep; 14(3):224-33. PubMed ID: 25152521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiovulatory and postcoital antifertility activity of the antiprogestin CDB-2914 when administered as single, multiple, or continuous doses to rats.
    Reel JR; Hild-Petito S; Blye RP
    Contraception; 1998 Aug; 58(2):129-36. PubMed ID: 9773268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of mifepristone (RU-486) as an emergency contraceptive drug.
    Sarkar NN
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):309-16. PubMed ID: 15762958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraceptive efficacy of daily administration of 0.5 mg mifepristone.
    Marions L; Viski S; Danielsson KG; Resch BA; Swahn ML; Bygdeman M; Kovâcs L
    Hum Reprod; 1999 Nov; 14(11):2788-90. PubMed ID: 10548623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifertility actions of the progesterone antagonist RU 486 include direct inhibition of placental hormone secretion.
    Das C; Catt KJ
    Lancet; 1987 Sep; 2(8559):599-601. PubMed ID: 2887889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase.
    Gemzell-Danielsson K; Svalander P; Swahn ML; Johannisson E; Bygdeman M
    Hum Reprod; 1994 Dec; 9(12):2398-404. PubMed ID: 7714164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-nidatory effect of a single, early post-ovulatory administration of mifepristone (RU 486) in the rhesus monkey.
    Ghosh D; Sengupta J
    Hum Reprod; 1993 Apr; 8(4):552-8. PubMed ID: 8501184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contranidatory activity of early luteal phase administration of mifepristone in the rhesus monkey.
    Ghosh D; De P; Sengupta J
    Indian J Physiol Pharmacol; 1993 Jan; 37(1):13-8. PubMed ID: 8449539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteal phase contraception with mifepristone (RU 486) in the rhesus monkey.
    Ghosh D; De P; Sengupta J
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):17-22. PubMed ID: 8132238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.